Immunovant, Inc. (IMVT) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Immunovant, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Immunovant, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $133 K, a 88.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $133 K -$1.04 M -88.7% Mar 31, 2024 10-K 2024-05-29
Q4 2023 $294 K -$1.17 M -79.8% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $589 K -$1.15 M -66.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $882 K -$1.14 M -56.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.17 M -$1.13 M -49.1% Mar 31, 2023 10-K 2024-05-29
Q4 2022 $1.46 M -$993 K -40.5% Dec 31, 2022 10-Q 2023-02-03
Q3 2022 $1.74 M -$988 K -36.2% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $2.02 M -$984 K -32.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $2.3 M -$979 K -29.8% Mar 31, 2022 10-K 2023-05-22
Q4 2021 $2.45 M -$1.02 M -29.3% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 $2.73 M -$762 K -21.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $3.01 M -$1.19 M -28.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.28 M +$3.28 M Mar 31, 2021 10-K 2022-06-08
Q4 2020 $3.47 M Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $3.49 M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $4.2 M Jun 30, 2020 10-K 2021-06-01
Q1 2020 $0 Mar 31, 2020 10-K 2021-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.